Latest Working Capital News

Hydrix Limited has launched the retail phase of its accelerated entitlement offer aiming to raise up to $8.18 million by issuing six new shares per existing share at $0.005 each, plus free options. The institutional component has closed, and retail shareholders have until 5 June to participate.

Sandon Capital is seeking noteholder approval to amend its 4.8% unsecured notes, offering an 8.5% fixed interest extension and monthly payments, alongside a $10 million conditional note placement.

Mt Malcolm Mines (ASX:M2M) is gearing up for a major drilling campaign at its Calypso Gold Prospect, aiming to convert a substantial Exploration Target into a JORC-compliant Mineral Resource. The program follows high-grade discoveries at the newly identified T3 Constance Lode and historical multi-lode mineralisation.

Service Stream is set to broaden its industrial services reach through the acquisition of Queensland’s RIE Group, a specialist in high-voltage electrical and instrumentation services. The deal enhances Service Stream’s market presence in key energy sectors amid ongoing contract wins.

Adore Beauty Group reports a 7.4% revenue rise in FY26 despite market headwinds and outlines ambitious FY27 targets backed by new stores and operational efficiencies.

Thrive Tribe Technologies’ 1TTO securities face immediate suspension from ASX pending regulatory compliance, isolating the impact to this class alone amid ongoing capital raises.

Anteris Technologies Global Corp. has initiated an at-the-market equity offering to raise up to US$250 million, aiming to accelerate development of its DurAVR transcatheter heart valve and support general corporate needs.

Coronado Global Resources has agreed to sell its Logan Mining Complex in West Virginia for nominal cash consideration, shifting liabilities to the buyer and aiming to sharpen focus on core metallurgical coal assets.

Corella Resources has completed due diligence on the Chobe Project tenements, advancing its plan to acquire a 75% stake from Caprice Resources. The project, rich in carbonatite potential, awaits final capital raising and regulatory approvals.

Vectus Biosystems has secured $791,000 through a placement to accelerate its lead fibrosis drug VB0004's Phase IB clinical trial and advance other drug candidates.

HIQ Limited has locked in non-dilutive funding from the Victorian Government to underpin a $4.9 million project expanding its manufacturing and research footprint in Victoria, supporting its global growth ambitions.

PainChek has secured A$5.5 million via convertible notes to accelerate its US sales expansion and strengthen working capital amid key commercial milestones.